Please login to the form below

Not currently logged in
Email:
Password:

Eucrisa

This page shows the latest Eucrisa news and features for those working in and with pharma, biotech and healthcare.

Daily brief: Novartis spends big on ezcema,

Daily brief: Novartis spends big on ezcema,

There is plenty of competition in the field, with Pfizer’s Eucrisa and Regeneron and Sanofi’s Dupixent already on the market.

Latest news

  • Dermira craters as acne drug fails late-stage test Dermira craters as acne drug fails late-stage test

    s IL-4 and IL-13-targeting drug Dupixent (dupilumab), Pfizer’s new topical treatment Eucrisa (crisaborole) and potentially other drugs such as GlaxoSmithKline’s asthma drug Nucala (mepolizumab), which is

  • Roche out-licenses lebrikizumab rights to Dermira Roche out-licenses lebrikizumab rights to Dermira

    Meanwhile, Pfizer is starting to make headway with its new topical treatment Eucrisa (crisaborole), which pulled in $17m in the first half of the year after its approval last December.

  • Regeneron bags US approval for eczema drug Dupixent Regeneron bags US approval for eczema drug Dupixent

    Dupixent's approval comes just a few weeks after Pfizer won a green light from the regulator for Eucrisa (crisaborole) for patients with milder forms of atopic dermatitis - which the company

  • Novartis adds oral eczema drug with Ziarco acquisition Novartis adds oral eczema drug with Ziarco acquisition

    The deal comes hard on the heels of Pfizer gaining FDA approval of its Eucrisa (crisaborole) topical treatment for eczema - also known as atopic dermatitis - which is predicted to become a

  • FDA green light for Pfizer's eczema drug FDA green light for Pfizer's eczema drug

    FDA green light for Pfizer's eczema drug. Blockbuster-hopeful Eucrisa expected to launch early next year at $580 per 60mg tube. ... The pharma leviathan has priced Eucrisa at $580 for a 60g tube, before any discounts or rebates, and expects to launch it

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics